VRTX
VRTX
NASDAQ · Biotechnology

Vertex Pharmaceuticals Inc

S&P 500 Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$436.95
-13.46 (-2.99%)
As of May 16, 1:01 AM ET ·
Analyst Consensus
Strong Buy
39
Analysts
Very High
Coverage
Buy 31 79%
Hold 7 18%
Sell 1 3%
Price Target
Analyst Price Target +0.3% upside
Low Target $313.95
Average Target $438.34
High Target $454.41
Current Price $436.95
Current
$436.95
Target
$438.34
$313.95 $438.34 avg $454.41
Scenario Analysis
Bear Case
$313.95
-28.1%
Low target
Base Case
$438.34
+0.3%
Avg target
Bull Case
$454.41
+4.0%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$507.92
-14.0% from high
52-Week Low
$362.50
+20.5% from low
50-Day SMA
$461.14
-5.2% vs SMA
200-Day SMA
$435.10
+0.4% vs SMA
RSI (14)
47.3
Neutral
Target vs 52W High
$438.34
-13.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
 Buy 43 56% $91.45 -52.6%